Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
February 10, 2025, By Martin David Harp Results were published from the phase 3 QUASAR trial and the extension study of the phase 3 PULSAR trial. Regeneron Pharmaceuticals has announced results…